KIWA Will Formally Submit Financial Statements To The OTC Markets
September 28, 2021 Based on the consensus reached with its restructuring partner, Kiwa Bio-Tech Products Group Corporation (KIWA, or the “Company”) has formally submitted an application to re-activate its account at the OTC Markets, and has paid related fees. The application is currently under the OTC Markets’ review. The Company’s legal counsel also urged the…